Article
Author(s):
In this podcast, Dr. Phil Hanno interviews Dr. Michael Chancellor on the potential role of botulinum toxin in urology.
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Study shows value of precision-based approaches in prostate cancer
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Patient selection for cytoreductive nephrectomy in 2025
SBRT may offer a safe alternative to CFRT after prostatectomy
Urologic surgeons successfully complete world’s first bladder transplant